期刊文献+

影响慢性乙型肝炎病毒感染患者肾功能的危险因素 被引量:3

Risk factors to influence renal function of patients with chronic hepatitis B virus infection
原文传递
导出
摘要 目的分析初治的慢性乙型肝炎病毒(HBV)感染患者的肾功能状况,探讨影响肾功能的危险因素。方法连续入组206例慢性HBV感染患者,其中慢性乙型肝炎(CHB)151例,乙型肝炎肝硬化55例,入组患者既往均未接受过抗病毒治疗。应用最新的CKD-EPI方程评估肾小球滤过率估计值(e GFR),评估入组患者肾功能受损[e GFR<90 m L/(min·1.73 m^2)]的发生率并分析肾功能异常的危险因素。结果 206例慢性HBV感染患者中肾功能受损的发生率为21.85%(45/206),CHB和乙型肝炎肝硬化患者肾功能受损发生率分别为17.88%(27/151)和32.73%(18/55),后者明显高于前者(χ~2=5.205,P=0.023)。年龄(≥50岁)及高血压病史为肾功能受损的独立危险因素。结论部分慢性HBV感染患者在进行抗病毒治疗前已存在肾功能异常,年龄和高血压病史为肾功能受损的危险因素。对慢性HBV感染患者应进行基线肾功能评估并定期监测肾功能。 Objective To assess the renal function of patients with chronic hepatitis B virus( HBV) infection and to explore the risk factors for renal dysfunction. Methods A total of 206 treatment-nave patients with chronic HBV infection were enrolled,including 151 cases of chronic hepatitis B( CHB) and 55 cases of liver cirrhosis. The renal function with estimated glomerular filtration rate( e GFR) was calculated with latest Chronic Kidney Disease Epidemiology Collaboration( CKD-EPI) equation. The prevalence of renal impairment [e GFR 90 m L /( min·1. 73 m^2) ]was evaluated and risk factors for renal abnormalities were analyzed. Results The total incidence of renal impairment was21. 85%( 45 /206),while it was 17. 88%( 27 /151) and 32. 73%( 18 /55) among CHB patients and liver cirrhosis patients,with the latter being significantly higher than the former( χ~2= 5. 205,P = 0. 023). Age( ≥50 years) and history of hypertension were identified as risk factors for renal impairment. Conclusions Renal abnormalities pre-exist in some patients with chronic HBV infection before the initiation of any antiviral treatment. Age and history of hypertension are identified as risk factors for renal impairment. We need to evaluate renal function in patients with chronic HBV infection at baseline and monitor renal function regularly.
出处 《山东大学学报(医学版)》 CAS 北大核心 2016年第1期29-32,37,共5页 Journal of Shandong University:Health Sciences
基金 艾滋病和病毒性肝炎等重大传染病防治和"十二五"国家科技重大专项(2013ZX10004902) 山东省医药卫生科技发展计划(2014WS0424)
关键词 慢性乙型肝炎 肾小球滤过率 肾功能受损 Chronic hepatitis B Glomerular filtration rate Renal function impairment
  • 相关文献

参考文献18

  • 1Combes B, Shorey J, Barrera A, et al. Glomerulonephri- tis with deposition of Australia antigen-antibody comple- xes in glomerular basement membraneE J. Lancet, 1971, 2(7718) : 234-237.
  • 2Zeng CH, Chen HM, Wang RS, et al. Etiology and clin- ical characteristics of membranous nephropathy in Chinese patientsEJl. Am J Kidney Dis, 2008, 52(4) : 691-698.
  • 3Ha NB, Ha NB, Garcia RT, et al. Renal dysfunction in chronic hepatitis B patients treated with adefovir dipivoxil EJ]. Hepatology, 2009, 50(3): 727-734.
  • 4Inker LA, Schmid CH, Tighiouart H, et al. Estimating glomerular filtration rate from serum creatinine and cysta- tin CEJ]. N Engl J Med, 2012, 367(1) : 20-29.
  • 5Inker LA, Astor BC, Fox CH, et al. KDOQI US com- mentary on the 2012 KDIGO clinical practice guideline for the evaluation and management of CKD J 3. Am J Kid- ney Dis, 2014, 63(5) : 713-735.
  • 6Thyagarajan SP, Thirunalasundari T, Subramanian S, et al. Serum and tissue positivity for hepatitis B virus mark- ers in histopathologically proven glomerulonephropathies EJJ. J Med Microbiol, 1989, 29(4) : 243-249.
  • 7Levey AS, Coresh J, Balk E, et al. National kidney foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification E J 1- Ann In- tem Med, 2003, 139(2) : 137-147.
  • 8钟爱民,刘燕鸣,陈红,魏小昌,李赟,刘精东.血清胱抑素-C是反映肾小球滤过功能的敏感指标[J].临床肾脏病杂志,2004,4(4):166-167. 被引量:22
  • 9Hemmelgarn BR, Manns B J, Lloyd A, et al. Relation between kidney function, proteinuria, and adverse out- comes[J]. JAMA, 2010, 303(5): 423-429.
  • 10刘红春,苏利沙,赵占正,韩星敏,李彦鹏,刘栋,张根豪,张俊华.血清胱抑素C评估慢性肾脏病患者肾小球滤过率的应用研究[J].中华检验医学杂志,2014,37(3):184-188. 被引量:42

二级参考文献24

  • 1王宇,贾继东.肝肾综合征的发生机制和治疗进展[J].肝脏,2006,11(1):45-47. 被引量:3
  • 2王学晶,徐国宾,李海霞,李淑葵,赵进荣,夏铁安.血清肌酐和半胱氨酸蛋白酶抑制剂C及估算的肾小球滤过率在评价慢性肾病患者肾小球滤过功能中的比较研究[J].中华检验医学杂志,2007,30(4):415-418. 被引量:42
  • 3韩振武,赵然,邵树茂,韩迎春.血清胱抑素C用以评估肾小球滤过率的价值[J].中国误诊学杂志,2007,7(18):4222-4223. 被引量:68
  • 4Randers E, Erlandsen EJ. Serum cystatin C as an endogenous marker of the renal function-a review. Clin Chem Lab Med. 1999; 37:389-395.
  • 5Herget. RS, Trabold S, Pietruck F, et al. Cystatin C: efficacy as screening test for reduced glomerular filtration rate. Am J Nephrol.2000, 20:97-102.
  • 6Randers E, Erlandsen EJ, Pedersen OL, et al. Serum cystatin C as an endogenous parameter of the renal function in patients with normal to moderately impaired kidney function. Clin Nephrol. 2000,54 : 203-209.
  • 7Dhamidharka VR, Kwon C, Stevens G. Serum cystatin C is superior to serum creatinine as a marker of kidney function: a meta-analysis. Am J Kidney Dis. 2002, 40:221-226.
  • 8National Kidney Foundation. K/DOQI Clinical practical guidelines for chronic kiddney disease: evalution classification,and stratification[ J]. Am J Kidney Dis, 2002, 39 : s1-s266.
  • 9LaterzaOF, PriceCP, ScottMG, et al. CystatinC: an improved estimator of glomerular filtration rate[ J] ? Clin Chem, 2002, 48 : 699 -707.
  • 10Stevens LA, Coresh J, Schmid CH, et al. Estimating GFR using serum eystatin C alone and in eombination with serum ereatinine:a pooled analysis of 3,418 individuals with CKD[J]. Am J Kidney Dis, 2008, 51:395-406.

共引文献81

同被引文献20

引证文献3

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部